![Robert Schier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Schier
Chief Executive Officer at
Bridging Minds SARL
Profile
Robert Schier is the founder of Bridging Minds SARL. Current positions include Vice Chairman at Creoptix AG, Director at medimaps group SA since 2022, Director at Memo Therapeutics AG, Director at Versantis AG, Investment Director at Swisscanto Invest, and Investment Directot at Seventure Partners SA. Former positions include Director at Cerecin, Inc., Director at MycoTechnology, Inc., Director at SelectX Pharmaceuticals, Inc., Director-Supervisory Board at DNage BV, Director at Xerion Pharmaceuticals AG, Non-Executive Director at ImmunoBiology Ltd., Director-Supervisory Board at AM-Pharma BV, Director at Opsona Therapeutics Ltd., Director at Humedics GmbH, Director at YSOPIA Biosciences SA, Senior Scientist & Project Leader at MorphoSys AG, Partner at Inventages Venture Capital Investment, Inc from 2002 to 2010, and Chief Operating Officer at Phytomedics, Inc. Education includes graduate and doctorate degrees from the University of Vienna and an MBA from European University Viadrina Frankfurt.
Robert Schier active positions
| Companies | Position | Start |
|---|---|---|
Bridging Minds SARL | Chief Executive Officer | - |
Memo Therapeutics AG
 Memo Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as a biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer | Director/Board Member | - |
Creoptix AG
 Creoptix AG BiotechnologyHealth Technology Provides biosensor devices for applications in drug discovery | Director/Board Member | - |
Versantis AG
 Versantis AG BiotechnologyHealth Technology Develops liver disease therapeutics and diagnostics services | Director/Board Member | - |
Medimaps Group SA
 Medimaps Group SA Packaged SoftwareTechnology Services Develops AI driven bone microarchitecture imaging solutions for healthcare professionals | Director/Board Member | 28/11/2022 |
Swisscanto Invest /Private Equity/
 Swisscanto Invest /Private Equity/ Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | - |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm targets companies operating in the fields of digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million. | Private Equity Investor | - |
Former positions of Robert Schier
| Companies | Position | End |
|---|---|---|
Phytomedics, Inc.
 Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops, and manufactures botanical therapeutics | Chief Operating Officer | 03/12/2012 |
DNage BV
 DNage BV Miscellaneous Commercial ServicesCommercial Services Provides DNA biopharmaceuticals research and experimental development services in the field of ageing related disorders | Director/Board Member | 21/08/2012 |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Robert Schier
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
22
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 22 |
|---|---|
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat central nervous system disorders | Health Technology |
MycoTechnology, Inc.
 MycoTechnology, Inc. Food: Specialty/CandyConsumer Non-Durables Operates as a food technology and ingredient company that focused on transforming food with natural fermentation & fungal biology | Consumer Non-Durables |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm targets companies operating in the fields of digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million. | Finance |
University of Vienna
 University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inventages Venture Capital Investment, Inc
 Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture invests in companies located across the globe. The firm targets companies operating in the fields of diagnostics, drugs, OTC, medical and functional foods, nutraceuticals and enabling technologies. It provides financing for seed and early stage capital requirements. | Finance |
SelectX Pharmaceuticals, Inc.
 SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops aminoglycoside therapeutics | Health Technology |
Phytomedics, Inc.
Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops, and manufactures botanical therapeutics | Health Technology |
DNage BV
DNage BV Miscellaneous Commercial ServicesCommercial Services Provides DNA biopharmaceuticals research and experimental development services in the field of ageing related disorders | Commercial Services |
Xerion Pharmaceuticals AG
 Xerion Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops antibodies and therapeutic targets | Health Technology |
ImmunoBiology Ltd.
 ImmunoBiology Ltd. BiotechnologyHealth Technology Develops next generation anti-infective vaccines | Health Technology |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
European University Viadrina Frankfurt
 European University Viadrina Frankfurt Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
Humedics GmbH
 Humedics GmbH Packaged SoftwareTechnology Services Develops diagnostic systems technology for assessment of liver diseases | Technology Services |
YSOPIA Biosciences SA
 YSOPIA Biosciences SA BiotechnologyHealth Technology Develops therapeutic solutions for metabolic and cardiometabolic disorders | Health Technology |
Creoptix AG
Creoptix AG BiotechnologyHealth Technology Provides biosensor devices for applications in drug discovery | Health Technology |
Medimaps Group SA
Medimaps Group SA Packaged SoftwareTechnology Services Develops AI driven bone microarchitecture imaging solutions for healthcare professionals | Technology Services |
Bridging Minds SARL | |
Memo Therapeutics AG
Memo Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as a biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer | Health Technology |
Versantis AG
Versantis AG BiotechnologyHealth Technology Develops liver disease therapeutics and diagnostics services | Health Technology |
Swisscanto Invest /Private Equity/
Swisscanto Invest /Private Equity/ Investment ManagersFinance Functions as an alternative investment manager | Finance |
- Stock Market
- Insiders
- Robert Schier
